Nicotinamide as a precursor for NAD+ prevents apoptosis in the mouse brain induced by tertiary-butylhydroperoxide

LK Klaidman, SK Mukherjee, TP Hutchin, JD Adams - Neuroscience letters, 1996 - Elsevier
LK Klaidman, SK Mukherjee, TP Hutchin, JD Adams
Neuroscience letters, 1996Elsevier
The vitamin nicotinamide can protect against oxidative stress-induced apoptosis in the brain
when used as a precursor for nicotinamide adenine dinucleotide (NAD+). The
intracerebroventricular administration of tertiary-butylhydroperoxide (t-buOOH) to mice was
used to simulate physiologic oxidative stress and apoptosis which may occur in some
neurodegenerative conditions. t-buOOH produced characteristic apoptotic nuclear
degeneration in neurons with extensive fragmentation of DNA. In this report we show that …
The vitamin nicotinamide can protect against oxidative stress-induced apoptosis in the brain when used as a precursor for nicotinamide adenine dinucleotide (NAD+). The intracerebroventricular administration of tertiary-butylhydroperoxide (t-buOOH) to mice was used to simulate physiologic oxidative stress and apoptosis which may occur in some neurodegenerative conditions. t-buOOH produced characteristic apoptotic nuclear degeneration in neurons with extensive fragmentation of DNA. In this report we show that the elevation of NAD+ levels can be increased by 50% in the brain. This may prevent the critical depletion of NAD+ by poly(ADP-ribose)polymerase (PARP) and provide additional substrate during the repair of DNA. Nicotinamide may be of particular interest in the treatment of neurodegeneration.
Elsevier